March special issue: What to do about Taiwan

COVID-19

A US national labs researcher studying viruses.

How to tell biodefense from an offensive bioweapons program

By Dan Regan, Rhys Dubin | Biosecurity

An anthrax-laced letter.

The Biden administration overestimates radiological terrorism risks and underplays biothreats

By Zachary Kallenborn | Biosecurity

The real horrors of ‘The Last of Us’ may already be here

By Erik English | Biosecurity

A House hearing on the origins of COVID.

A House subcommittee investigating COVID-19’s origins hears from a former CDC head and other prominent witnesses

By Matt Field | Biosecurity

A covid test.

How to minimize COVID’s impacts once the federal emergency “ends”

By Lynn Klotz, Jonas Sandbrink | Biosecurity

The smallpox virus.

Private-sector research could pose a pandemic risk. Here’s what to do about it

By Gerald L. Epstein | Biosecurity

Peter Hotez at his desk in a white physician coat

Viral spread: Peter Hotez on the increase of anti-science aggression on social media

By Sara Goudarzi | Disruptive Technologies

A biosafety level 4 lab.

Researchers hacked a lab’s pathogen containment system. Was it a good idea to publish the results?

By George Poste, David Gillum | Biosecurity

The A1 Haiku: Power’s trips

By Thomas Gaulkin | Biosecurity, Special Topics

How a deliberate pandemic could crush societies and what to do about it

By Kevin Esvelt | Biosecurity

This 3D illustration shows a large virus hovering over the entire population of the world in a representation of the threat pandemics posed to everyone. illustration

Investing in pandemic prevention is essential to defend against future outbreaks

By Bridget Williams, Will MacAskill | Biosecurity, Disruptive Technologies

Boston University

After the fact: Another controversial virus study raises questions about US government oversight

By David Gillum, Kathleen M. Vogel | Biosecurity